Abstract

BackgroundLife expectancy in rheumatoid arthritis (RA) patients is reduced by 3-10 years mainly due to cardiovascular diseases. Cystatin C is a basic microprotein, widely distributed in human tissues and body...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis.
Bartłomiej Kisiel ... Aleksandra Juszkiewicz
Pakistan journal of medical sciences | VOL. 31
Bartłomiej Kisiel, et. al.Bartłomiej Kisiel ... Aleksandra Juszkiewicz
01 Jan 2015
Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media
Y.Niv Sherer ... Rosita Allegrucci
Annals of the New York Academy of Sciences | VOL. 1051
Y.Niv Sherer, et. al.Y.Niv Sherer ... Rosita Allegrucci
01 Jun 2005
AB0559 Progression of atherosclerosis in premenopausal rheumatoid arthritis patients treated with biological drugs – a five year follow up study
M Koren Krajnc ... R Hojs
Annals of the Rheumatic Diseases | VOL. 71
M Koren Krajnc, et. al.M Koren Krajnc ... R Hojs
01 Jun 2013
AB0327 Progression of Atherosclerosis in Premenopausal Rheumatoid Arthritis Patients Treated with Methotrexate – A Five Year Follow up Study
I Holc ... M Koren Krajnc
Annals of the Rheumatic Diseases | VOL. 73
I Holc, et. al.I Holc ... M Koren Krajnc
01 Jun 2014
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers